MedicaidCoverageMedium impact
MSA 21-21
Michigan Medicaid - MDHHS·MI · Infectious Disease, Family Medicine, Internal Medicine·Provider Bulletin
Effective date
May 6, 2021
We identified it
Jun 20, 2026
Summary
Michigan Medicaid will now reimburse home health agencies for administering FDA Emergency Use Authorization monoclonal antibody COVID-19 infusions at 100% of Medicare rates during the Public Health Emergency. The drugs themselves are provided free by the federal government and should be billed at $0.00.
Action Required
Immediately: Home health agencies must use appropriate HCPCS codes for EUA monoclonal antibody COVID-19 infusion administration found at the Michigan COVID-19 Response database. Bill drug costs at $0.00 since federally supplied for free. Document that EUA terms are met and evaluate safety/efficacy to support medical necessity. Ensure compliance with Medicare Conditions of Participation regulations at 42 CFR §484.60.